Agios Pharmaceuticals
AGIO
#4992
Rank
S$2.43 B
Marketcap
S$40.67
Share price
-0.54%
Change (1 day)
-30.60%
Change (1 year)

Earnings for Agios Pharmaceuticals (AGIO)

Earnings in 2026 (TTM): -S$0.6 Billion

According to Agios Pharmaceuticals 's latest financial reports the company's current earnings are S$98.33 Million. In 2025 the company made an earning of -S$0.61 Billion a decrease over its 2024 earnings that were of -S$0.55 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agios Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$0.6 Billion-2.72%
2025 -S$0.61 Billion10.9%
2024 -S$0.55 Billion8.75%
2023 -S$0.51 Billion0.63%
2022 -S$0.51 Billion2.81%
2021 -S$0.49 Billion10.58%
2020 -S$0.45 Billion-18.41%
2019 -S$0.54 Billion15.72%
2018 -S$0.47 Billion12.99%
2017 -S$0.42 Billion59.61%
2016 -S$0.26 Billion69.32%
2015 -S$0.16 Billion119.28%
2014 -S$69.69 Million39.22%
2013 -S$50.06 Million69.1%
2012 -S$29.61 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$8.97 B-1,618.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$44.75 B-7,674.59%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$9.21 B-1,658.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
-S$0.15 Billion-74.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
S$1.37 B-332.20%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$56.21 M-109.51%๐Ÿ‡บ๐Ÿ‡ธ USA